Abstract
Background: Rising levels of oxidative stress play an important role in the pathogenesis of type 2 diabetes mellitus. Therefore, we investigated the serum level of 8-hydroxy-2-deoxy-guanosine (8-OHdG) as an early oxidative stress marker in patients with prediabetes and with type 2 diabetes mellitus.
Subjects and methods: Convenience sampling from people attending a diabetes screening clinic. Participants at the rural diabetes screening clinic had their medical history recorded as well as body mass index, blood glucose, cholesterol, glutathione, malondialdehyde, fasting blood glucose and 8-OHdG measured. Statistical analysis was performed using ANOVA followed by Sheffe posthoc test for between-group differences.
Results: The 8-OHdG level was significantly greater in the prediabetes (516.5 ± 260 pg/ml) compared to control group (177.8 ± 91 pg/ml; P < 0.01). The diabetes group (1926.9 ± 1197 pg/ml) had the highest level of 8-OHdG, being approximately four times greater compared to the prediabetes group (P < 0.001). No significant change in the cholesterol profile, MDA level indicative of lipid peroxidation and antioxidant activity as measured by erythrocyte reduced glutathione was observed in the prediabetes group compared to the control group (P > 0.05).
Conclusions: 8-OHdG levels in both the prediabetes and diabetes group were increased from control values suggesting a role for 8-OHdG as an early disease marker that may be more sensitive compared to cholesterol, MDA and erythrocyte reduced glutathione levels, which were within normal limits. This is of clinical significance as 8-OHdG is a strong indicator of oxidative stress related DNA damage within blood vessel walls and other tissue that increases the risk of cardiovascular disease.
Keywords: 8-HYDROXY-2-DEOXY-GUANOSINE, OXIDATIVE DNA DAMAGE, ERYTHROCYTE REDUCED GLUTATHIONE, PREDIABETES, TYPE 2 DIABETES
Full Text
The Full Text of this article is available as a PDF (139.1 KB).
References
- 1.Mehta JL, Rasouli N, Sinha AK, Molavi B. Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction. Int J Biochem Cell B 2006; 38: 794–803. [DOI] [PubMed] [Google Scholar]
- 2.Huebschmann AG, Regensteiner JG, Vlassara H, Reusch JEB. Diabetes and advanced glycoxidation end products. Diabetes Care 2006; 29: 1420–1432. [DOI] [PubMed] [Google Scholar]
- 3.Sheetz MJ, King GL. Molecular understanding of hyperglycemia's adverse effects of diabetic complications JAMA 2002; 288: 255579-252589. [DOI] [PubMed]
- 4.Nwose E, Jelinek H, Richards R, Kerr P. Oxidative stress and related cardiovascular events: Biomarkers improve CAD screening in prediabetes. Br J Biomed Sci 2007; 64: 35–43. [DOI] [PubMed] [Google Scholar]
- 5.Hinokio Y, Suzuki S, Hirai M, Suzuki C, Suzuki M, Toyota T. Urinary excretion of 8-oxo-7,8-dihydro-2-deoxyguanosine as a predictor of the development of diabetic nephropathy. Diabetologia 2002; 45: 877–882. [DOI] [PubMed] [Google Scholar]
- 6.Akhtar N. Is homocysteine a risk factor for atherothrombotic cardiovascular disease? J Am Coll Cardiol 2007; 49: 1370-1371. [DOI] [PubMed] [Google Scholar]
- 7.Stocker R, Keaney JE Role of oxidative modifications in atherosclerosis Physiol Rev 2004; 84: 1381-1478. [DOI] [PubMed] [Google Scholar]
- 8.Nwose EU, Jelinek HF, Richards RS, Kerr PG. Erythrocyte oxidative stress in clinical management of diabetes and its cardiovascular complication: a review. Br J Biomed Sci 2007; 64: 35–43. [DOI] [PubMed] [Google Scholar]
- 9.Nwose EU, Jelinek HF, Richards RS, Kerr PG. Changes in the erythrocyte glutathione concentration in the course of diabetes mellitus Redox Rep 2006; 11: 99–104. [DOI] [PubMed] [Google Scholar]
- 10.Cersosimo E, DeFronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res 2006; 22: 423–436. [DOI] [PubMed] [Google Scholar]
- 11.Kopprasch S, Pietzsch J, Kuhlisch E et al. In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance. Diabetes 2002; 51: 3102–3106. [DOI] [PubMed] [Google Scholar]
- 12.Wright E, Scism-Bacon JL, Glass LC. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int J Clin Pract 2006; 60: 308–314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Yoshida K, Hirokawa J, Tagami S, Kawakami Y, Urata Y Kondo T. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux. Diabetologia 1995; 38: 201–210. [DOI] [PubMed] [Google Scholar]
- 14.Nwose E, Jelinek H, Richards R. Changes in malondialdehyde level in diabetes. The Australian Health and Medical Research Congress, Sydney 208,2004.
- 15.Callum L, James D. Targeting therapeutics against glutathione depletion in diabetes and its complications Br J Diabetes Vase Dis 2007; 7: 258–265. [Google Scholar]
- 16.Hochstein P, Atallah AS. The nature of oxidants and antioxidant systems in the inhibition of mutation and cancer. Mutat Res 1988; 202: 363–375. [DOI] [PubMed] [Google Scholar]
- 17.Neilsen F, Mikkelsen B, Neilsen J, Andersen H, Grandjean P. Plasma malondialdehyde as biomarker for oxidative stress reference interval and effects of life-style factors. Clin Chem 1997; 47: 1209–1214. [PubMed] [Google Scholar]
- 18.Slatter DA, Bolton CH, Bailey AJ. The importance of lipid-derived malondialdehyde in diabetes mellitus. Diabetologia 2000; 43: 550–557. [DOI] [PubMed] [Google Scholar]
- 19.Lucijan M. The level of maternal methemoglobin during pregnancy in an air-polluted environment. Environ Health Perspect 2003; 111: 1902–1905. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Balla J, Balla G, Jeney V, Kakuk G, Jacob H, Vercellofi G. Ferriporphyrins and endothelium. A 2-edged sword. Promotion of oxidation and induction of cytoprotectants. Blood 2000; 95: 3442–3450. [PubMed] [Google Scholar]
- 21.Loft S, Poulsen HE. Cancer risk and oxidative DNA damage in man. J Mol Med 1966; 74: 297–312. [DOI] [PubMed] [Google Scholar]
- 22.Tuzgen S, Hanimoglu H, Tanriverdi T et al. Relationship between DNA damage and total antioxidant capacity in patients with glioblastoma multiforme. Clin Oncol 2007; 19: 177–181. [DOI] [PubMed] [Google Scholar]
- 23.Le Page F, Margot A, Grollman AP, Sarasin A, Gentile A. Mutagenicity of a unique 8-oxoguanine in a Ha-ras sequence in mammalian cells. Carcinogenesis 1995; 16: 2779–2784. [DOI] [PubMed] [Google Scholar]
- 24.American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27: s5–s10. [DOI] [PubMed] [Google Scholar]
- 25.Stocks J, Dormandy TL. The autooxidation of human red cell lipids induced by hydrogen peroxide Br J Haematol 1971; 20: 95–111. [DOI] [PubMed] [Google Scholar]
- 26.Evelyn K, Malloy H. Microdetermination of oxyhemoglobin, methemoglobin and sulfhemoglobin in a single sample of blood. J Biol Chem 1938; 126:655. [Google Scholar]
- 27.Noiri E, Nakao A, Uchida K et al. Oxidative and nitrosative stress in acuterenal ischemia. Am J Physiol 2001; 281: F948–F957. [DOI] [PubMed] [Google Scholar]
- 28.Beutler E, Duran O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963; 64: 822–888. [PubMed] [Google Scholar]
- 29.Lowry O, Passonneau J, Hasselberger F, Schulz D. Effects of ischemia on known substrates and cofactors of the glycolytic pathway in the brain. J Biol Chem 1964; 239: 18. [PubMed] [Google Scholar]
- 30.Hinokio Y, Suzuki M, Hirai M, Chiba M, Hirai A, Toyota T. Oxidative DNA damage in diabetes mellitus: its association with diabetic complications Diabetologia 1999; 42: 995-998. [DOI] [PubMed] [Google Scholar]
- 31.Nwose E, Jelinek H, Richards R, Kerr P. Erythrocyte oxidative stress in clinical management of diabetes and its cardiovascular complications Br J Biomed Sci 2007; 64: 35–43. [DOI] [PubMed] [Google Scholar]
- 32.Bjornhjolt JV, Erikssen G, Aaser E et al. Fasting blood glucose: an underestimated risk factor for cardiovascular death: results from a 22-year follow-up of healthy non-diabetic men. Diabetes Care 1999; 22: 45–49. [DOI] [PubMed] [Google Scholar]
- 33.Deedwania P, Fonseca V. Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm. Am J Med 2005; 118: 939–947. [DOI] [PubMed] [Google Scholar]
- 34.Levitan EB, Song Y, Ford ES, Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 2004; 164: 2147–2155. [DOI] [PubMed] [Google Scholar]
- 35.American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2005; 28 (Suppl 1): S37–S42. [DOI] [PubMed] [Google Scholar]
- 36.Baynes J, Thorpe S. Role of oxidative stress in diabetic complications. Diabetes Care 1999; 48: 1–9. [DOI] [PubMed] [Google Scholar]
- 37.Suzuki S, Hinokio Y, Komatsu K et al. Oxidative damage to mitochondrial DNA and its relationship to diabetic complications. Diabetes Res Clin Pract 1999; 45: 161–168. [DOI] [PubMed] [Google Scholar]
- 38.Maura L, Lisa G, Vanessa P, Ellisabeta B, Gianluca B, Carlo Maria R. Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycemic control. Mutat Res 2008; 638: 98–102. [DOI] [PubMed] [Google Scholar]
- 39.Choi S, Choi H, Lee S, Ko S, You H, Ye S. Anti-inflammatory effect of 8-hydroxy-2-deoxyguanosine on lipopolysaccharide-induced inflammation via rac suppression in Balb/c mice. Free Radic Biol Med 2007; 43: 1594–1603. [DOI] [PubMed] [Google Scholar]
- 40.Kim J, Choi S, Yoo J, Chung M. 8-oxoguanine induces intramolecular DNA damage but free 8-oxoguanine protects intermolecular DNA from oxidative stress. FEBS Lett 2004; 556: 104–110. [DOI] [PubMed] [Google Scholar]
- 41.Ro JY, Kim DY, Park JW, Chung MH. Effects of 7,8-dihydro-8-oxo-deoxyguanosine on antigen challenge in ovalbumin-sensitized mice may be mediated by suppression of rac. Br J Pharmacol 2009; 158: 1743–1752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Dyer RG, Stewart MW, Mitcheson J, George K, Alberti MM, Laker ME. 7-Ketocholesterol, a specific indicator of lipoprotein oxidation, and malondialdehyde in non-insulin dependent diabetes and peripheral vascular disease Clin Chim Acta 1998; 260: 1-13. [DOI] [PubMed] [Google Scholar]
- 43.Dincer Y, Akcay T, Alademir Z, llkova H. Effect of oxidative stress on glutathione pathway in red blood cells from patients with insulin-dependent diabetes mellitus Metabolism 2002; 51: 1360–1362. [DOI] [PubMed] [Google Scholar]
- 44.Woo KS, (look P, Lolin YI et al. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans Am Heart J 1997; 96: 2542-2544. [DOI] [PubMed] [Google Scholar]